SSGJ-705

· Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SSGJ-705, covering 2024-10-18 to 2025-08-03. Get the full timeline:

Most recent: Clinical Trial Update: SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors [Phase 2]